Aerovate Therapeutics
AVTE
#8977
Rank
NZ$99.15 M
Marketcap
$3.43
Share price
1.67%
Change (1 day)
-84.49%
Change (1 year)

Aerovate Therapeutics (AVTE) - Total debt

Total debt on the balance sheet as of June 2024 : NZ$1.1 M

According to Aerovate Therapeutics's latest financial reports the company's total debt is NZ$1.1 M. A companyโ€™s total debt is the sum of all current and non-current debts.

Aerovate Therapeutics - Total debt on balance sheet (from 2020 to 2024)

Total debt by year

Year Total debt Change
2022-12-31NZ$1.71 M104.83%
2021-12-31NZ$0.83 M
2020-12-31N/A-100%
2019-12-31NZ$3.7 M